CB2 receptor‐selective agonists as candidates for targeting infection, inflammation, and immunity in SARS‐CoV ‐2 infections
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CB2
receptor‐selective agonists as candidates for targeting infection, inflammation, and immunity in
SARS‐CoV
‐2 infections
Authors
Keywords
-
Journal
DRUG DEVELOPMENT RESEARCH
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-11-15
DOI
10.1002/ddr.21752
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Guide to Targeting the Endocannabinoid System in Drug Design
- (2020) Adam Stasiulewicz et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Letter: intestinal inflammation, COVID-19 and gastrointestinal ACE2-exploring RAS inhibitors. Authors’ reply
- (2020) Carlos Taxonera et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Immunological and inflammatory profiles in mild and severe cases of COVID-19
- (2020) Jin-Wen Song et al. Nature Communications
- COVID-19 and mental health: A review of the existing literature
- (2020) Ravi Philip Rajkumar Asian Journal of Psychiatry
- Current Status of COVID-19 Therapies and Drug Repositioning Applications
- (2020) Ozlem Altay et al. iScience
- Pathophysiology of COVID-19: Mechanisms Underlying Disease Severity and Progression
- (2020) Mary Kathryn Bohn et al. PHYSIOLOGY
- Anti-inflammatory mechanisms of cannabinoids: an immunometabolic perspective
- (2019) G. van Niekerk et al. INFLAMMOPHARMACOLOGY
- PPAR-γ in macrophages limits pulmonary inflammation and promotes host recovery following respiratory viral infection
- (2019) Su Huang et al. JOURNAL OF VIROLOGY
- Cannabinoid receptor 2 deficiency exacerbates inflammation and neutrophil recruitment
- (2019) Theodore S. Kapellos et al. FASEB JOURNAL
- Cannabinoids and the expanded endocannabinoid system in neurological disorders
- (2019) Luigia Cristino et al. Nature Reviews Neurology
- Cannabinoid receptor 2: a potential novel therapeutic target for sepsis?
- (2018) Qianwen He et al. ACTA CLINICA BELGICA
- Emerging strategies targeting CB 2 cannabinoid receptor: Biased agonism and allosterism
- (2018) Paula Morales et al. BIOCHEMICAL PHARMACOLOGY
- Cannabinoid receptor 2-63 RR variant is independently associated with severe necroinflammation in HIV/HCV coinfected patients
- (2017) Caterina Sagnelli et al. PLoS One
- Peroxisome Proliferators Activated Receptor (PPAR) agonists activate hepatitis B virus replication in vivo
- (2017) Lingyao Du et al. Virology Journal
- Effects of cannabinoid receptor type 2 in respiratory syncytial virus infection in human subjects and mice
- (2017) Alireza Tahamtan et al. Virulence
- Targeting Cannabinoid Signaling in the Immune System: “High”-ly Exciting Questions, Possibilities, and Challenges
- (2017) Attila Oláh et al. Frontiers in Immunology
- An update on PPAR activation by cannabinoids
- (2016) Saoirse Elizabeth O'Sullivan BRITISH JOURNAL OF PHARMACOLOGY
- Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice
- (2016) Rudragouda Channappanavar et al. Cell Host & Microbe
- Human lung-resident macrophages express CB1 and CB2 receptors whose activation inhibits the release of angiogenic and lymphangiogenic factors
- (2015) Rosaria I. Staiano et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Association Between a Polymorphism in Cannabinoid Receptor 2 and Severe Necroinflammation in Patients With Chronic Hepatitis C
- (2013) Nicola Coppola et al. Clinical Gastroenterology and Hepatology
- Attenuation of HIV-1 replication in macrophages by cannabinoid receptor 2 agonists
- (2013) Servio H. Ramirez et al. JOURNAL OF LEUKOCYTE BIOLOGY
- CNR2 functional variant (Q63R) influences childhood immune thrombocytopenic purpura
- (2011) F. Rossi et al. HAEMATOLOGICA
- Association of the cannabinoid receptor 2 (CB2) Gln63Arg polymorphism with indices of liver damage in obese children: An alternative way to highlight the CB2 hepatoprotective properties
- (2011) Francesca Rossi et al. HEPATOLOGY
- Is lipid signaling through cannabinoid 2 receptors part of a protective system?
- (2011) P. Pacher et al. PROGRESS IN LIPID RESEARCH
- 1-Bromo-3-(1′,1′-dimethylalkyl)-1-deoxy-Δ8-tetrahydrocannabinols: New selective ligands for the cannabinoid CB2 receptor
- (2010) John W. Huffman et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Influence of Psychological Stress on Upper Respiratory Infection—A Meta-Analysis of Prospective Studies
- (2010) Anette Pedersen et al. PSYCHOSOMATIC MEDICINE
- PPAR-γ Activation As an Anti-inflammatory Therapy for Respiratory Virus Infections
- (2010) Josep Bassaganya-Riera et al. VIRAL IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now